昂利康股价报50.56元 创新药板块政策利好频现

Core Viewpoint - The stock price of Anglikang closed at 50.56 yuan on August 22, 2025, reflecting a decline of 1.56% from the previous trading day, with a trading volume of 433 million yuan and a turnover rate of 4.64% [1] Company Overview - Anglikang operates in the chemical pharmaceutical sector, focusing on the research, production, and sales of pharmaceutical products. The company is recognized as an innovative drug concept stock, with products spanning various therapeutic areas including anti-infectives, cardiovascular, and digestive systems [1] Industry Developments - The innovative drug industry has recently received multiple policy supports. In early July, the National Healthcare Security Administration and the National Health Commission issued measures to support the high-quality development of innovative drugs, which include adding innovative drug listings to commercial health insurance and facilitating their entry into medical insurance directories [1] - Progress has also been made in the internationalization of innovative drugs, with several domestic pharmaceutical companies reaching cooperation agreements with multinational pharmaceutical firms [1] Capital Flow - On August 22, Anglikang experienced a net inflow of 3.6583 million yuan in principal funds, with a total net inflow of 135 million yuan over the past five days [1]